Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Buy, Sell, or Hold: Astex Pharmaceuticals
Let's take a look at Astex Pharmaceuticals (NASDAQ: ASTX ) today and see why you might want to buy, sell, or hold it. Founded in 1991 and based in California, Astex is a biotech company that specializes in small-molecule therapeutics and focuses ...
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described �Euro mutt,� joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Astex Pharmaceuticals Inc Stock Downgraded (ASTX)
ASTEX PHARMACEUTICALS INC has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Outline of the Tender Offer 1) Offeror in the Public Tender Offer Autumn Acquisition Corporation 2) Company Subject to the Public Tender Offer Astex Pharmaceuticals, Inc. 3) Type of Stock that is to be Acquired All issued and outstanding shares of ...
Related articles »  
Acquisition of Astex Pharmaceuticals, Inc. by Otsuka Pharmaceutical Co., Ltd ...
SAN DIEGO and DUBLIN, Calif., Sept. 5, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) ("Astex") by Otsuka Pharmaceutical Co., Ltd. ("Otsuka").
Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals for $8.50 Per Share ...  MarketWatch
Otsuka Holdings Says It Hasn't Yet Decided to Buy Astex  Bloomberg
Related articles »  
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
OrbiMed Advisors, managed by Samuel Isaly, initiated the most outsized position in Astex Pharmaceuticals, Inc. (NASDAQ:ASTX).
Related articles »  
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Astex Pharma To Submit IND Application To FDA For ASTX727 - Quick Facts  RTT News
Related articles »  
Expecting Catalyst Action For Astex Pharmaceuticals
Shares of Astex Pharmaceuticals (NASDAQ:ASTX), the drug discovery company formed by the acquisition of Astex Therapeutics Ltd by Supergen Inc. In 2011 have been on the move. The firm has a wide variety of products in development, and currently ...
Related articles »  
Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum
We believe that Astex Pharmaceuticals' (NASDAQ:ASTX) shares represent an excellent buying opportunity. Despite positive recent developments at Astex, the company has seemingly gotten lost in the shuffle, with shares slumping sharply - more than 35 ...
Related articles »